Lastly, we blocked BRD4 binding to the CD47 breast cancer SE, by using the inhibitors I-BET151 and PFI-1 and we observed a reduction on TNF-α mediated CD47 upregulation in MCF7 cells (Supplementary Fig. 6e). Here, BRD4 is linked to breast carcinoma.